Literature DB >> 19584313

LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism.

Marnix Jansen1, Jean Paul Ten Klooster, G Johan Offerhaus, Hans Clevers.   

Abstract

Research on the LKB1 tumor suppressor protein mutated in cancer-prone Peutz-Jeghers patients has continued at a feverish pace following exciting developments linking energy metabolism and cancer development. This review summarizes the current state of research on the LKB1 tumor suppressor. The weight of the evidence currently indicates an evolutionary conserved role for the protein in the regulation of various aspects of cellular polarity and energy metabolism. We focus on studies examining the concept that both cellular polarity and energy metabolism are regulated through the conserved LKB1-AMPK signal transduction pathway. Recent studies from a variety of model organisms have given new insight into the mechanism of polyp development and cancer formation in Peutz-Jeghers patients and the role of LKB1 mutation in sporadic tumorigenesis. Conditional LKB1 mouse models have outlined a tissue-dependent context for pathway activation and suggest that LKB1 may affect different AMPK isoforms independently. Elucidation of the molecular mechanism responsible for Peutz-Jeghers syndrome will undoubtedly reveal important insight into cancer development in the larger population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584313     DOI: 10.1152/physrev.00026.2008

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  94 in total

1.  Probucol suppresses human glioma cell proliferation in vitro via ROS production and LKB1-AMPK activation.

Authors:  Yong-sheng Jiang; Jing-an Lei; Fang Feng; Qi-ming Liang; Fu-rong Wang
Journal:  Acta Pharmacol Sin       Date:  2014-11-17       Impact factor: 6.150

2.  Primary cilia regulate mTORC1 activity and cell size through Lkb1.

Authors:  Christopher Boehlke; Fruzsina Kotsis; Vishal Patel; Simone Braeg; Henriette Voelker; Saskia Bredt; Theresa Beyer; Heike Janusch; Christoph Hamann; Markus Gödel; Klaus Müller; Martin Herbst; Miriam Hornung; Mara Doerken; Michael Köttgen; Roland Nitschke; Peter Igarashi; Gerd Walz; E Wolfgang Kuehn
Journal:  Nat Cell Biol       Date:  2010-10-24       Impact factor: 28.824

Review 3.  Apicobasal polarity of brain endothelial cells.

Authors:  Thomas Worzfeld; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-06       Impact factor: 6.200

4.  Promoting Axon Regeneration in Adult CNS by Targeting Liver Kinase B1.

Authors:  Yosuke Ohtake; Armin Sami; Xinpei Jiang; Makoto Horiuchi; Kieran Slattery; Lena Ma; George M Smith; Michael E Selzer; Shin-Ichi Muramatsu; Shuxin Li
Journal:  Mol Ther       Date:  2018-11-01       Impact factor: 11.454

5.  Akt blocks the tumor suppressor activity of LKB1 by promoting phosphorylation-dependent nuclear retention through 14-3-3 proteins.

Authors:  Ling Liu; Fung-Ming Siu; Chi-Ming Che; Aimin Xu; Yu Wang
Journal:  Am J Transl Res       Date:  2012-04-10       Impact factor: 4.060

6.  Crystallization and preliminary crystallographic analysis of the chimeric protein LKB1-14-3-3ζ.

Authors:  Sheng Ding; Ruiqing Zhou; Yaqin Zhu
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-11-29

Review 7.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

8.  Lkb1/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation.

Authors:  Lick Pui Lai; Brendan N Lilley; Joshua R Sanes; Andrew P McMahon
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 9.  Controlling the master-upstream regulation of the tumor suppressor LKB1.

Authors:  Lars Kullmann; Michael P Krahn
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

10.  Synergistic effects of eukaryotic coexpression plasmid carrying LKB1 and FUS1 genes on lung cancer in vitro and in vivo.

Authors:  Lingdong Li; Chuanjiang Yu; Jiang Ren; Sujuan Ye; Wenjing Ou; Yu Wang; Weihan Yang; Guoxing Zhong; Xiang Chen; Huashan Shi; Xiaolan Su; Lijuan Chen; Wen Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2014-06       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.